[Practical notes for the evaluation of malignancy in digestive endocrine tumors]

Area of Science:

• Endocrinology
• Oncology
• Pathology

Context:

• Digestive endocrine tumors previously lacked reliable malignancy risk and outcome data.
• The 2000 World Health Organization (WHO) classification established a standardized pathological reporting scheme.
• This classification provides a framework for assessing tumor malignancy and guiding patient management.

Purpose:

• To review and summarize the differential tumor characteristics within the 2000 WHO classification of digestive endocrine tumors.
• To discuss the relevance of additional prognostic features, such as the Ki67 proliferation index and genetic changes.
• To emphasize discrepancies in prognostication between foregut and midgut endocrine tumors.

Summary:

• The 2000 WHO classification categorizes digestive endocrine tumors into well-differentiated (benign/uncertain), well-differentiated carcinomas (low grade), and poorly differentiated carcinomas (high grade).
• This system facilitates standardized assessment of malignancy and patient outcomes.
• Key prognostic indicators include the Ki67 proliferation index and specific genetic alterations.

Impact:

• Improved clinical decision-making and treatment protocol design for digestive endocrine tumors.
• Enhanced understanding of tumor behavior and prognosis based on standardized pathological criteria.
• Identification of organ-specific differences (foregut vs. midgut) impacting tumor prognostication.